Surrozen, Inc. (SRZN)
Surrozen Market Cap : 380.21M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 380.21M |
| November 12, 2026 | 380.93M |
| November 11, 2026 | 383.45M |
| November 10, 2026 | 392.59M |
| November 09, 2026 | 384.90M |
| November 06, 2026 | 372.87M |
| November 05, 2026 | 348.81M |
| November 04, 2026 | 372.01M |
| November 03, 2026 | 354.03M |
| November 02, 2026 | 341.10M |
| October 30, 2026 | 341.34M |
| October 29, 2026 | 346.27M |
| October 28, 2026 | 356.73M |
| October 27, 2026 | 347.10M |
| October 26, 2026 | 320.65M |
| October 23, 2026 | 299.49M |
| October 22, 2026 | 302.67M |
| October 21, 2026 | 297.61M |
| October 20, 2026 | 295.50M |
| October 19, 2026 | 280.22M |
| October 16, 2026 | 275.51M |
| October 15, 2026 | 294.67M |
| October 14, 2026 | 279.16M |
| October 13, 2026 | 276.34M |
| October 12, 2026 | 291.03M |
| Date | Value |
|---|---|
| October 09, 2026 | 348.98M |
| October 08, 2026 | 328.76M |
| October 07, 2026 | 295.55M |
| October 06, 2026 | 309.95M |
| October 05, 2026 | 342.39M |
| October 02, 2026 | 344.63M |
| October 01, 2026 | 352.62M |
| September 30, 2026 | 378.24M |
| September 29, 2026 | 375.89M |
| September 28, 2026 | 348.39M |
| September 25, 2026 | 347.21M |
| September 24, 2026 | 395.87M |
| September 23, 2026 | 189.94M |
| September 22, 2026 | 206.87M |
| September 21, 2026 | 194.29M |
| September 18, 2026 | 194.53M |
| September 17, 2026 | 199.11M |
| September 16, 2026 | 199.00M |
| September 15, 2026 | 208.87M |
| September 14, 2026 | 209.69M |
| September 11, 2026 | 223.33M |
| September 10, 2026 | 228.62M |
| September 09, 2026 | 235.43M |
| September 08, 2026 | 243.07M |
| September 04, 2026 | 267.52M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 46.12M |
| Sangamo Therapeutics, Inc. | 48.47M |
| Sarepta Therapeutics, Inc. | 1.723B |
| Anixa Biosciences, Inc. | 90.61M |
| Vicapsys Life Sciences, Inc. | 16.19M |
Market Cap Related Metrics
| PS Ratio | 41.26 |
| PEG Ratio | -0.0059 |
| Price | 31.61 |
| Earnings Yield | -148.5% |
| PEGY Ratio | -0.0059 |